GEMMS

MAY 22, 2024

This improves diagnostic accuracy and ultimately leads to better patient outcomes. Artificial Intelligence Artificial intelligence (AI) has revolutionized cardiac diagnosis by allowing for the analysis of extensive patient data to identify patterns and predict outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

HeartRhythm

APRIL 30, 2024

Current guidelines for implantable cardioverter defibrillators (ICD), primarily based on LV ejection fraction (LVEF) are sub-optimal and have limitations.

Sudden Cardiac Death 40

Sudden Cardiac Death Biomarkers Heart Disease Defibrillator 40

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Serum troponins and CK-MB (creatine kinase-MB) are readily detectable and reliable cardiac-specific biomarkers of subclinical myocardial injury. This study explores the roles of cTnI (cardiac troponin I) and CK-MB in hypertrophic cardiomyopathy (HCM).Methods:This

Biomarkers 40

Biomarkers Sudden Cardiac Death Coronary Artery Bypass Graft Cardiomyopathy 40

The British Journal of Cardiology

DECEMBER 3, 2024

Protection against the increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias is offered by the implantation of cardiac defibrillators. This is a single-centre retrospective study on the outcomes of all patients who had a transvenous defibrillator implant in 2015. Data from 235 patients were analysed.

Defibrillator 40

Defibrillator Sudden Cardiac Death Biomarkers Arrhythmia 40

DAIC

DECEMBER 19, 2023

Better stratification of risk, the researchers say, would help clinicians to identify people in need of an implantable cardioverter defibrillator (ICD) – a device that monitors heart rhythm and shocks the heart back into a normal rhythm if needed.

Sudden Cardiac Death 105

Sudden Cardiac Death Heart Rhythm Biomarkers Cardiomyopathy 105